Lowell Farms Inc. Announces Unaudited Second Quarter 2024 Financial and Operational Results
SALINAS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis…
Pharmaceuticals, Biotechnology and Life Sciences
SALINAS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis…
• AMPLIFY-7P Phase 1 preliminary disease-free (“DFS”) survival demonstrates strong correlation between T cell response and reduced risk of progression…
– Sutro will present updated data from the ongoing Phase 1b study of luvelta in combination with bevacizumab in a…
SUNNYVALE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the…
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its…
HERA will procure 175,420 doses for immediate response to the concerning mpox outbreak in Africa, and furthermore, Bavarian Nordic will…
MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of…
– Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid…
AI Technology to Assist Clinicians to Drive Better Outcomes in Brain HealthTORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Firefly Neuroscience,…
PDUFA goal date of November 4, 2024 for DFD-29 for the treatment of inflammatory lesions and erythema of rosacea in…